United Therapeutics Corporation (UTHR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$495.5
Day's range
$530.47

United Therapeutics Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 5.40 M $3.20 B   4.43% 12.19%
AVORO CAPITAL ADVISORS LLC 05/15/2026 2.63 M $1.56 B   0.92% 5.94%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 2.26 M $1.34 B   -7.26% 5.11%
05/08/2026 2.00 M $1.19 B   100.00% 4.52%
05/15/2026 1.96 M $1.16 B   100.00% 4.42%
STATE STREET CORP 05/15/2026 1.84 M $1.09 B   0.08% 4.16%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 1.79 M $1.06 B   -6.40% 4.03%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.23 M $729.92 M   3.35% 2.78%
JANUS HENDERSON GROUP PLC 05/18/2026 866.93 K $514.02 M   8.90% 1.96%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 826.23 K $486.42 M   -35.54% 1.87%
CAPTION MANAGEMENT, LLC 05/15/2026 667.20 K $395.64 M   199.46% 1.51%
ASSETMARK, INC 05/06/2026 616.05 K $365.31 M   -2.98% 1.39%
INVESCO LTD. 05/12/2026 608.37 K $360.75 M   -0.06% 1.37%
FMR LLC 05/15/2026 528.35 K $313.30 M   30.83% 1.19%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 512.74 K $304.03 M   -2.93% 1.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 476.00 K $282.26 M   160.82% 1.07%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2026 457.00 K $270.99 M   7.28% 1.03%
NORTHERN TRUST CORP 05/14/2026 436.57 K $258.87 M   4.34% 0.99%
BAILLIE GIFFORD & CO 05/08/2026 428.13 K $253.87 M   32.54% 0.97%
CAPTION MANAGEMENT, LLC 05/15/2026 410.00 K $243.12 M   156.57% 0.93%
MORGAN STANLEY 05/15/2026 409.29 K $242.70 M   5.14% 0.92%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 405.45 K $240.42 M   15.16% 0.92%
LSV ASSET MANAGEMENT 05/11/2026 398.67 K $236.40 M   -2.30% 0.90%
AVORO CAPITAL ADVISORS LLC 05/15/2026 380.00 K $10.30 M   100.00% 0.86%
CITADEL ADVISORS LLC 05/15/2026 360.64 K $213.85 M   92.69% 0.81%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 356.80 K $211.58 M   16.95% 0.81%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 05/14/2026 343.66 K $203.78 M   15.98% 0.78%
BANK OF NEW YORK MELLON CORP 05/05/2026 329.15 K $195.18 M   -1.34% 0.74%
SWEDBANK AB 04/29/2026 327.12 K $193.98 M   0.72% 0.74%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 309.22 K $183.31 M   0.78% 0.70%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 300.48 K $178.18 M   3.64% 0.68%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 300.20 K $177.98 M   49.70% 0.68%
JPMORGAN CHASE & CO 05/13/2026 291.62 K $171.58 M   11.21% 0.66%
FULLER & THALER ASSET MANAGEMENT, INC. 05/14/2026 280.41 K $166.27 M   -3.51% 0.63%
FRANKLIN RESOURCES INC 05/13/2026 277.98 K $164.84 M   53.48% 0.63%
FIRST TRUST ADVISORS LP 05/13/2026 270.58 K $160.45 M   23.54% 0.61%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 267.98 K $158.91 M   100.00% 0.60%
EVERSEPT PARTNERS, LP 05/15/2026 264.27 K $156.71 M   4.62% 0.60%
FRONTIER CAPITAL MANAGEMENT CO LLC 05/15/2026 252.70 K $149.85 M   39.48% 0.57%
LORD, ABBETT & CO. LLC 05/14/2026 250.28 K $148.41 M   -3.01% 0.57%
PACER ADVISORS, INC. 06/18/2026 243.55 K $144.42 M   0.69% 0.55%
UBS GROUP AG 05/05/2026 236.73 K $140.38 M   4.82% 0.53%
CITIGROUP INC 05/11/2026 235.62 K $139.72 M   27.77% 0.53%
ALLIANCEBERNSTEIN L.P. 05/15/2026 220.63 K $107.50 M   6.82% 0.50%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 207.31 K $122.93 M   1.95% 0.47%
BANK OF AMERICA CORP /DE/ 05/18/2026 199.43 K $118.26 M   -2.78% 0.45%
DEUTSCHE BANK AG\ 05/06/2026 198.78 K $117.87 M   59.69% 0.45%
NUVEEN, LLC 04/30/2026 190.70 K $113.08 M   -24.27% 0.43%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 187.19 K $111.00 M   211.98% 0.42%
LEGAL & GENERAL GROUP PLC 05/08/2026 186.79 K $110.77 M   7.61% 0.42%

United Therapeutics Corp institutional Ownership - FAQ's

During the previous two years, 1149 institutional investors and hedge funds held shares of United Therapeutics Corp. The most heavily invested institutionals were:

BlackRock, Inc.: 5.4 M

Avoro Capital Advisors LLC: 2.63 M

WELLINGTON MANAGEMENT GROUP LLP: 2.26 M

STATE STREET CORP: 1.84 M

RENAISSANCE TECHNOLOGIES LLC: 1.79 M

GEODE CAPITAL MANAGEMENT, LLC: 1.23 M

93.65% of United Therapeutics Corp stock is owned by institutional investors.

Institutional investors have bought a total of 57.99 M shares in the last 24 months. This purchase volume represents approximately $30.68 B in transactions.